Cg Oncology Inc (NASDAQ: CGON) is -15.73% lower on its value in year-to-date trading and has touched a low of $14.80 and a high of $40.47 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CGON stock was last observed hovering at around $24.18 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $24.17, the stock is 1.00% and 0.87% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.01 million and changing -0.04% at the moment leaves the stock -21.55% off its SMA200. CGON registered -15.19% loss for a year compared to 6-month loss of -39.48%.
The stock witnessed a 20.49% gain in the last 1 month and extending the period to 3 months gives it a -13.68%, and is 8.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.60% over the week and 8.48% over the month.
Cg Oncology Inc (CGON) has around 113 employees, a market worth around $1.84B and $0.66M in sales. Profit margin for the company is -15945.17%. Distance from 52-week low is 63.31% and -40.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.96%).
The EPS is expected to shrink by -34.35% this year
The shares outstanding are 76.22M, and float is at 46.04M with Short Float at 24.38%.
The top institutional shareholder in the company is DECHENG CAPITAL LLC with over 5.46 million shares valued at $172.33 million. The investor’s holdings represent 8.1903 of the CGON Shares outstanding. As of 2024-06-30, the second largest holder is TCG CROSSOVER MANAGEMENT, LLC with 3.67 million shares valued at $115.87 million to account for 5.5067 of the shares outstanding. The other top investors are BRAIDWELL LP which holds 3.31 million shares representing 4.9655 and valued at over $104.48 million, while BVF INC/IL holds 3.6278 of the shares totaling 2.42 million with a market value of $76.33 million.
Cg Oncology Inc (CGON) Insider Activity
The most recent transaction is an insider sale by POST LEONARD E, the company’s Director. SEC filings show that POST LEONARD E sold 1,000 shares of the company’s common stock on Apr 28 ’25 at a price of $30.76 per share for a total of $30760.0. Following the sale, the insider now owns 0.0 shares.
Cg Oncology Inc disclosed in a document filed with the SEC on Mar 17 ’25 that POST LEONARD E (Director) sold a total of 1,000 shares of the company’s common stock. The trade occurred on Mar 17 ’25 and was made at $28.00 per share for $28000.0. Following the transaction, the insider now directly holds 0.0 shares of the CGON stock.
Still, SEC filings show that on Mar 17 ’25, LEONARD E POST (Director) Proposed Sale 4,000 shares at an average price of $27.80 for $0.11 million. The insider now directly holds shares of Cg Oncology Inc (CGON).
